A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: Secondary analysis of a randomized controlled trial

Psychosomatic Medicine

Volumn 71, Issue 7, 2009, Pages 715-724

  Thornton, Lisa M ^a   Andersen, Barbara L ^a,b   Schuler, Tammy A ^a   Carson, William E ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Depression; Fatigue; Inflammation; Pain; Psychological intervention; White blood cell count

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER PATIENT; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FATIGUE; FEMALE; HELPER CELL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL OUTCOMES STUDY-SHORT FORM 36 BODILY PAIN SUBSCALE; MOOD; MULTIMODALITY CANCER THERAPY; NEUTROPHIL COUNT; PAIN; PRIORITY JOURNAL; PROFILE OF MOOD STATES DEPRESSION AND FATIGUE SUBSCALE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SECONDARY ANALYSIS; SHORT FORM 36;

BEHAVIOR THERAPY; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER; FATIGUE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTE COUNT; NEUTROPHILS; PAIN; PSYCHOTHERAPY; T-LYMPHOCYTES, HELPER-INDUCER; TREATMENT OUTCOME;

EID: 70349678525     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181b0545c     Document Type: Article

References (51)

1. Raison CL, Miller AH. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003;54:283-294
2. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L. Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life. Qual Life Res 2005;14:1825-1833
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545
4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867
5. Shankar A, Wang JJ, Rochtchina E, Yu M, Kefford R, Mitchell P. Association between circulating white blood cell count and cancer mortality: a population-based cohort study. Arch Intern Med 2006;166: 188-194
6. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychological factors contribute to cancer incidence and survival: a systematic review and meta-analysis. Nat Clin Pract Oncol 2008;5:466-475
7. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-186
8. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman DA, Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15:199-226.
9. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252-1257
10. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003;170:429-433
11. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 1995;762:474-476
12. Frommberger UH, Bauer J, Haselbauer P, Fräulin A, Riemann D, Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997;247:228-233
13. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000;22:370-379
14. Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003;19:183-188
15. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:201-217
16. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
17. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res 1996;711:163-174
18. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 1999;80:1770-1780
19. Andersen BL, Farrar WB, Golden-Kreutz DM, Emery CF, Glaser R, Crespin TR, Carson WE. Distress reduction from a psychological intervention contributes to improved health for cancer patients. Brain Behav Immun 2007;21:953-961
20. Andersen BL, Farrar WB, Golden-Kreutz DM, Glaser R, Emery CF, Crespin TR, Shapiro CL, Carson WE 3rd. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J Clin Oncol 2004;22:3570-3580
21. Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, Miller AH, Payne R, Reuben JM, Wang XS, Lee B-N. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer 2003;97:2919-2925
22. NIH State-of-the-Science Statement on symptom management in cancer: pain, depression, and fatigue. NIH Consens State Sci Statements 2002; 19:1-29.
23. Rose NR, Hamilton RG, Detrick B. Manual of Clinical Laboratory Immunology. Washington, DC: ASM Press; 2002.
24. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-1482
25. Shankar A, Klein BE, Klein R. Relationship between white blood cell count and incident hypertension. Am J Hypertens 2004;17:233-239
26. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G. Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): a cohort study. Lancet 1999;353:1649-1652 (Pubitemid 29224520)
27. Eyles JL, Roberts AW, Metcalf D, Wicks IP. Granulocyte colonystimulating factor and neutrophils-forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2006;2:500-510
28. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4- T lymphocytopenia. Ann Intern Med 1993;119:55-62.
29. Moodley YP, Dorasamy T, Venketasamy S, Naicker V, Lalloo UG. Correlation of CD4:CD8 ratio and tumour necrosis factor (TNF)alpha levels in induced sputum with bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 2000;55:696-699
30. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995;19: 11-38.
31. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D Depression Symptoms Index. J Aging Health 1993; 5:179-193
32. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, editor. Evaluation of Chemotherapeutic Agents. New York: Columbia University; 1949.
33. Dimidjian S, Hollon SD, Dobson KS, Schmaling KB, Kohlenberg RJ, Addis ME, Gallop R, McGlinchey JB, Markley DK, Gollan JK, Atkins DC, Dunner DL, Jacobson NS. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006;74:658-670
34. McNair DM, Lorr M, Droppleman LF. Profile of Mood States. San Diego, CA: Educational and Industrial Testing Services; 1971.
35. Ware JE, Snow KK, Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: QualityMetric; 2000.
36. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 1984;53:2002-2007
37. Moinpour CM, Feigl P, Metch B, Hayden KA, Meyskens FL Jr, Crowley J. Quality of life end points in cancer clinical trials: review and recommendations. J Natl Cancer Inst 1989;81:485-495
38. Kristal AR, Shattuck AL, Henry HJ, Fowler AS. Rapid assessment of dietary intake of fat, fiber, and saturated fat: validity of an instrument suitable for community intervention research and nutritional surveillance. Am J Health Promot 1989;4:288-295
39. Blair SN, Haskell WL, Ho P, Paffenbarger RS Jr, Vranizan KM, Farquhar JW, Wood PD. Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 1985;122:794-804.
40. SPSS 16.0 for Windows. Chicago: SPSS; 2008.
41. Andersen BL, Shelby RA, Golden-Kreutz DM. RCT of a psychological intervention for patients with cancer: I. Mechanisms of change. J Consult Clin Psychol 2007;75:927-938
42. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002;7:83-104.
43. Shrout PE, Bolger N. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 2002; 7:422-445
44. Arbuckle JL. Amos 16.0 [computer software]. Spring House, PA: SPSS; 1995-2007.
45. Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, Muderspach L, Russell C. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol 2005;23:3052-3060
46. Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A. How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 1998;83:1640-1651
47. Linden M, Zubraegel D, Baer T, Franke U, Schlattmann P. Efficacy of cognitive behaviour therapy in generalized anxiety disorders. Results of a controlled clinical trial. Psychother Psychosom 2005;74:36-42.
48. Miller GE, Rohleder N, Stetler C, Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med 2005;67:679-687
49. Atanackovic D, Kröger H, Serke S, Deter HC. Immune parameters in patients with anxiety or depression during psychotherapy. J Affect Disord 2004;81:201-209
50. Thornton LM, Andersen BL, Carson WE III. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother 2008;57:1471-1481
51. Andersen BL, Yang H-C, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LM, Young DC, Carson WE. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer 2008;113:3450-3458